Removal of Toxoplasma gondii cysts from the brain by perforin-mediated activity of CD8+ T cells. - Wikidata - wikimedia - TriplyDB

Removal of Toxoplasma gondii cysts from the brain by perforin-mediated activity of CD8+ T cells.

Removal of Toxoplasma gondii cysts from the brain by perforin-mediated activity of CD8+ T cells.

http://www.wikidata.org/entity/Q33745093

about

Interferon-gamma- and perforin-mediated immune responses for resistance against Toxoplasma gondii in the brain Microglia development and function Recombinant vaccines against T. gondii: comparison between homologous and heterologous vaccination protocols using two viral vectors expressing SAG1 Chitinase dependent control of protozoan cyst burden in the brain Analysis of behavior and trafficking of dendritic cells within the brain during toxoplasmic encephalitis Characteristics and critical function of CD8+ T cells in the Toxoplasma-infected brain.The protein kinase double-stranded RNA-dependent (PKR) enhances protection against disease cause by a non-viral pathogen.The CD8 T-cell road to immunotherapy of toxoplasmosis.VCAM-1/α4β1 integrin interaction is crucial for prompt recruitment of immune T cells into the brain during the early stage of reactivation of chronic infection with Toxoplasma gondii to prevent toxoplasmic encephalitis.Toxoplasma IgG and IgA, but not IgM, antibody titers increase in sera of immunocompetent mice in association with proliferation of tachyzoites in the brain during the chronic stage of infection Towards an immunosense vaccine to prevent toxoplasmosis: protective Toxoplasma gondii epitopes restricted by HLA-A*0201 CD8 T Cells and Toxoplasma gondii: A New Paradigm Evidence for finely-regulated asynchronous growth of Toxoplasma gondii cysts based on data-driven model selection.MyD88-dependent protective immunity elicited by adenovirus 5 expressing the surface antigen 1 from Toxoplasma gondii is mediated by CD8(+) T lymphocytes.Toxoplasma gondii inhibits granzyme B-mediated apoptosis by the inhibition of granzyme B function in host cells Toxoplasma gondii superinfection and virulence during secondary infection correlate with the exact ROP5/ROP18 allelic combination.Protective efficacy of recombinant canine adenovirus type-2 expressing TgROP18 (CAV-2-ROP18) against acute and chronic Toxoplasma gondii infection in mice.Immune aging, dysmetabolism, and inflammation in neurological diseases.Mechanisms of Toxoplasma gondii persistence and latency.Novel Approaches Reveal that Toxoplasma gondii Bradyzoites within Tissue Cysts Are Dynamic and Replicating Entities In Vivo PD-1-mediated attrition of polyfunctional memory CD8+ T cells in chronic toxoplasma infection Toxoplasma gondii antigens recognized by IgG antibodies differ between mice with and without active proliferation of tachyzoites in the brain during the chronic stage of infection.CD73-generated adenosine facilitates Toxoplasma gondii differentiation to long-lived tissue cysts in the central nervous system.CD8(+) T cells remove cysts of Toxoplasma gondii from the brain mostly by recognizing epitopes commonly expressed by or cross-reactive between type II and type III strains of the parasite Donor CD8+ T cells prevent Toxoplasma gondii de-encystation but fail to rescue the exhausted endogenous CD8+ T cell population.IL-7 and IL-15 do not synergize during CD8 T cell recall response against an obligate intracellular parasite.Toxoplasmosis in the fetus and newborn: an update on prevalence, diagnosis and treatment.Complex immune cell interplay in the gamma interferon response during Toxoplasma gondii infection Dynamic two-photon imaging of the immune response to Toxoplasma gondii infection.CD8+ T cell immunity in an encephalitis model of Toxoplasma gondii infection.Hypometabolism as the ultimate defence in stress response: how the comparative approach helps understanding of medically relevant questions.Molecular and virulence characterization of Toxoplasma gondii strains isolated from humans in Portugal.Determination of a Key Antigen for Immunological Intervention To Target the Latent Stage of Toxoplasma gondii.In vivo effect of anti-TNF agent (etanercept) in reactivation of latent toxoplasmosis.A Bradyzoite is a Bradyzoite is a Bradyzoite?Induction of IL-10-producing regulatory B cells following Toxoplasma gondii infection is important to the cyst formation.Inducible nitric oxide synthase in innate immune cells is important for restricting cyst formation of Toxoplasma gondii in the brain but not required for the protective immune process to remove the cysts.Evaluation of the adjuvant effect of pidotimod on the immune protection induced by UV-attenuated Toxoplasma gondii in mouse models.Toxoplasmosis PD-L1, TIM-3, and CTLA-4 blockade fail to promote resistance to secondary infection with virulent strains of

P2860

Q27011746-B538A204-1AFE-43B2-A7D9-220527AF8849 Q27316453-058D1D9D-E4DE-47D8-95AA-0C3EB5F2AAA2 Q27321063-C21826E1-52B3-4531-82F8-96E23D0A4744 Q27341871-0F1304B8-B43F-4D3E-B4B4-9EBC59C6DC32 Q27349006-83F8F1AD-9D89-4917-B572-B2627E282BB9 Q30354096-6062B772-A1EC-4949-BF83-641E872F040A Q31129671-8BCB60A0-8994-4470-A948-A79E10D196EB Q33732215-8DB9C3C9-B150-4FAF-8F3C-3DDECBEE4DB4 Q33899681-F8FC23D0-2D20-4F1E-9172-46EF61886219 Q34388502-09856C45-4872-4A6A-9CF9-B60886DDDB31 Q34458916-66C8596C-5A58-48B0-808C-C5E579E505E1 Q35038836-F8944CDD-AAB8-46D5-A048-3208A8E9E21F Q35045376-98F90C44-6547-4494-A2C5-85022AC893E2 Q35046630-8C8BD108-45D0-45C9-BBDD-DA700400A319 Q35050044-A0148280-203D-450F-AA0E-E40340DC8CF7 Q35172341-191B5687-B2BD-408E-AB91-3BFAE503E715 Q35425382-18A60E69-4C16-4B44-9457-371EE2F0B8F5 Q35677347-8C22E49B-8973-4354-A48F-FD3FF84E5D45 Q35870650-B8AC6675-0827-43EC-AA08-75339AA13B2B Q36143596-8723573E-8446-4845-A639-6928E7B8E7E2 Q36154143-FAA97D13-1C54-4D80-A4D9-321B7D886D55 Q36277374-C55E97E4-2C56-443A-B91E-83C28C707306 Q36343044-F166E85C-485B-4456-94D3-0F66B570BD92 Q37052967-4A25901E-CF95-41D7-B2A4-3BFA57F06FC1 Q37123725-41912240-AC81-4798-B175-B7BBB5B91C0F Q37158941-16AF9F05-4743-49CF-B61D-385438A5501C Q38040154-48DB1838-90A1-4B28-B386-90761839EF9F Q38215371-686E077E-18EE-4825-9ECA-0C3E9ED4BD8D Q38269405-B93610D6-D350-4E5B-B63E-E19612F188D4 Q38461484-AE861C7B-C748-4B0B-B9D0-FC751380A3A7 Q38882599-FB92EAC4-E728-4EBB-9F03-E29C03854610 Q38990695-F4D218C4-D6B1-4158-B10E-E58580463FEE Q40236213-230B377D-EBE1-479A-A2AA-9531411566EB Q40439491-172DE13F-EC7B-41AC-8561-5D23AB82DFFA Q40931700-3565227F-C17C-4015-80FC-E747F8DCF039 Q41682999-79862624-F979-401E-A93B-2947DDFCB31E Q47890464-5BB976F5-8ABC-40A8-8E32-5F83D3B731E4 Q50893682-AC369A04-E9AC-4DBF-AFA1-0017D51BFF4F Q56768394-48D7C126-A507-4A52-AF88-C6A4A18517E2 Q56891292-F3FB8C11-AA05-4ECC-80DD-51E8AFDD03E2

P2860

Removal of Toxoplasma gondii cysts from the brain by perforin-mediated activity of CD8+ T cells.

http://www.wikidata.org/entity/Q33745093

description

2010 nî lūn-bûn

@nan

2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Removal of Toxoplasma gondii c ...... ated activity of CD8+ T cells.

@ast

Removal of Toxoplasma gondii c ...... ated activity of CD8+ T cells.

@en

type

label

Removal of Toxoplasma gondii c ...... ated activity of CD8+ T cells.

@ast

Removal of Toxoplasma gondii c ...... ated activity of CD8+ T cells.

@en

prefLabel

Removal of Toxoplasma gondii c ...... ated activity of CD8+ T cells.

@ast

Removal of Toxoplasma gondii c ...... ated activity of CD8+ T cells.

@en

P1433

Q33745093-108C88A8-BB60-4629-94D6-A7061DE2BF36

P1476

Q33745093-D5068F79-91F0-46BB-B833-3776BB182F34

P2093

Q33745093-0E7613C5-6FD4-4DE0-99D3-B53245620456

Q33745093-22D6B1BC-B5F8-41B6-A15C-55F05EF107E5

Q33745093-2C37B2BE-9510-47FC-B71A-13FE05BA1318

Q33745093-394DD50C-08DF-468A-A068-BB54A80C3E15

Q33745093-39BE4F13-E6EA-4FA6-B24B-C57229EB1A82

Q33745093-7223D093-7116-4132-9587-939AAD66F620

Q33745093-AFE5DA0C-076E-4F9B-98D9-FDC816E5EAEA

Q33745093-CA678E6C-123B-4062-BFE6-3909850872E3

P2860

Q33745093-021BB032-D511-4845-9264-6BA8E7FD0DDF

Q33745093-039A0EAF-CC4D-435C-A742-7197701160C4

Q33745093-063D2429-D551-4396-9BF3-68DC1D602D26

Q33745093-13A28A48-C420-4D88-A908-5E6EACAE49BB

Q33745093-2305873D-4F40-4929-8FE1-F91E4FD04F3D

Q33745093-293A9B2B-EB4E-4151-9CE9-7BB27D816650

Q33745093-303BDC11-D855-45EA-9F42-03C156E27A67

Q33745093-381D304D-ECE4-499A-9937-F372C229016B

Q33745093-3B771E53-9A8E-4098-A425-ED6AD6B285F8

Q33745093-43255781-6EF3-4F7E-9F5A-FDDB6F135730

P304

Q33745093-A72C110D-6435-47DC-AB8A-20624DFBD704

P31

Q33745093-5F7E7F20-2E5C-4FDC-AADB-0600069A2B50

P356

Q33745093-F30A8A27-836B-4360-ADCD-98742AF6FF1C

P407

Q33745093-38E5F085-E942-4CD9-9D8E-7861538A4D12

P433

Q33745093-B7B99B04-B207-470A-B6C6-78B5A6ABAD3F

P478

Q33745093-53C4C332-78F9-4DB8-86AE-7104E39B0A98

P50

Q33745093-F010573E-6458-4787-A770-F7AC3DCECBF8

P577

Q33745093-F2AC12BF-461F-44EE-BAE6-33424E12CA9F

P5875

Q33745093-171A4414-AD44-406F-920B-94B013035D10

P698

Q33745093-960CDA09-5184-476B-8397-95588222CE39

P921

Q33745093-4F93ABA1-96A9-4BD0-8732-73F13AA320EF

P932

Q33745093-AD83B663-168F-4AFF-8F49-44DC57B0AAE5

P356

AJPATH.2010.090825

P1433

The American Journal of Pathology

P1476

Removal of Toxoplasma gondii c ...... iated activity of CD8+ T cells

@en

P2093

Baohui Xu

http://www.w3.org/2001/XMLSchema#string

Benard S Jortner

http://www.w3.org/2001/XMLSchema#string

Sara A Michie

http://www.w3.org/2001/XMLSchema#string

Sara Perkins

http://www.w3.org/2001/XMLSchema#string

Tomoya Kudo

http://www.w3.org/2001/XMLSchema#string

Xisheng Wang

http://www.w3.org/2001/XMLSchema#string

Yanyan Ni

http://www.w3.org/2001/XMLSchema#string

Yasuhiro Suzuki

http://www.w3.org/2001/XMLSchema#string

P2860

Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis

Prevalence of Toxoplasma infection in first-episode schizophrenia and comparison between Toxoplasma-seropositive and Toxoplasma-seronegative schizophrenia

Susceptibility to chronic infection with Toxoplasma gondii does not correlate with susceptibility to acute infection in mice.

Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection.

Requirement of non-T cells that produce gamma interferon for prevention of reactivation of Toxoplasma gondii infection in the brain

Cryptogenic epilepsy: an infectious etiology?

Production of gamma interferon by natural killer cells from Toxoplasma gondii-infected SCID mice: regulation by interleukin-10, interleukin-12, and tumor necrosis factor alpha.

Human CD4+ and CD8+ T lymphocytes are both cytotoxic to Toxoplasma gondii-infected cells.

Interleukin 12 is required for the T-lymphocyte-independent induction of interferon gamma by an intracellular parasite and induces resistance in T-cell-deficient hosts.

Gamma interferon production, but not perforin-mediated cytolytic activity, of T cells is required for prevention of toxoplasmic encephalitis in BALB/c mice genetically resistant to the disease.

P304

1607-1613

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2353/AJPATH.2010.090825

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

176

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-02-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41486509

http://www.w3.org/2001/XMLSchema#string

P698

20167872

http://www.w3.org/2001/XMLSchema#string

P921

Toxoplasma gondii

P932

2843452

http://www.w3.org/2001/XMLSchema#string